K Pharma,Inc.
4896株式会社ケイファーマ
Latest half-year results
First half · fiscal year to 2026-12 · filed 2026-08-13For the first half of the fiscal year to 2026-12: Ordinary income ¥-0.5 billion, Net income ¥-0.5 billion.
| This period | Year on year | |
|---|---|---|
| Ordinary profit | −¥485m | — |
| Net profit to owners | −¥493m | — |
From the securities report on EDINET, which states no forecast. History via /v1/companies/4896/earnings-releases.
Financials
Japan GAAP · non-consolidated · fiscal year to 2025-12-31- Revenue
- —
- Net income
- −¥993m
- ROE
- —
- Equity ratio
- 43.1%
- Dividend / share
- —
- Employees
- 20
| Fiscal year | Revenue | Net income | Total assets | Net assets | ROE | EPS | Operating CF |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | — | −¥993m | ¥2,939m | ¥1,265m | — | ¥-85.59 | −¥918m |
| 2024-12-31 | — | −¥846m | ¥2,353m | ¥2,258m | — | ¥-72.94 | −¥984m |
| 2023-12-31 | ¥1,000m | ¥260m | ¥3,314m | ¥3,105m | 11.7% | ¥25.42 | ¥454m |
| 2022-12-31 | — | −¥392m | ¥1,375m | ¥1,336m | — | ¥-42.06 | −¥363m |
| 2021-12-31 | — | −¥229m | ¥206m | ¥179m | — | ¥-30.09 | −¥196m |
Indicators
Computed by us from filings · fiscal year to 2025-12-31| Metric | Value | Percentile among listed companies |
|---|---|---|
| ROE, % | — | — |
| Ordinary margin | — | — |
| Equity ratio, % | 43.1 | 31.4 |
| Revenue growth | — | — |
| Net income growth | -0.1734 | 24.1 |
| Operating cash flow / assets | -0.3123 | 1.6 |
Via /v1/companies/4896/indicators. Descriptive figures, not a rating and not investment advice.
From other filings
As the company states themSegments, votes and tender offers
Stated in EDINET filings/v1/companies/4896/votingOwnership changes
All companies →- 2026-04-13
individual filer reduced holdings in K Pharma,Inc. (4896) to 10.03% from 11.05%.
- 2025-05-02
individual filer reduced holdings in K Pharma,Inc. (4896) to 11.05% from 11.09%.
- 2025-04-07
ITOCHU Technology Ventures, Inc. filed a correction to a 5% report on K Pharma,Inc. (4896).
- 2025-04-04
SBI Investment Co., Ltd. reduced holdings in K Pharma,Inc. (4896) to 15.10% from 17.08%.
- 2025-04-03
SBI Investment Co., Ltd. reduced holdings in K Pharma,Inc. (4896) to 17.08% from 19.14%.
- 2025-04-02
SBI Investment Co., Ltd. reduced holdings in K Pharma,Inc. (4896) to 19.14% from 20.68%.
- 2025-04-02
Holdings of SBI Investment Co., Ltd. in K Pharma,Inc. (4896) moved below 20% (20.68% -> 19.14%).
- 2025-03-31
ITOCHU Technology Ventures, Inc. cut holdings in K Pharma,Inc. (4896) to 2.02% from 5.13%, below the 5% threshold.
- 2024-06-19
ITOCHU Technology Ventures, Inc. reduced holdings in K Pharma,Inc. (4896) to 5.13% from 6.19%.
- 2023-11-28
SBI Investment Co., Ltd. reduced holdings in K Pharma,Inc. (4896) to 20.68% from 22.84%.
Trades by 5% holders
From the 60-day trade tables in 5% reports| Holder | Period | Net shares | Net % of shares | Avg. filed price | Range |
|---|---|---|---|---|---|
| SBIインベストメント株式会社 | 2025-03-26 – 2025-03-28 | -650,000 | −5.60pt | — | — |
| 株式会社SBI証券 | 2023-10-18 – 2025-03-28 | +252,000 | +2.15pt | — | — |
| 伊藤忠テクノロジーベンチャーズ株式会社 | 2024-05-31 – 2025-03-26 | -421,600 | −3.63pt | — | — |
| SBI Ventures Two株式会社 | 2023-10-17 – 2023-10-17 | +210,500 | +1.82pt | ¥950 | ¥950–950 |
Net shares and the average are our calculations. Prices are filed prices as stated by the filer, mostly for off-market trades; they are not market prices. Stock lending, custody transfers and option exercises are excluded from net shares. Every row via /v1/companies/4896/trades.
5% filings
Large shareholding reports on 4896| Filed | Filer | Stake | Change | Stated purpose |
|---|---|---|---|---|
| 2026-04-13 | individual filer | 10.03% | −1.02pt | — |
| 2025-05-02 | individual filer | 11.05% | −0.04pt | — |
| 2025-04-07 | ITOCHU Technology Ventures, Inc. | 5.13% | −1.06pt | pure investment |
| 2025-04-04 | SBI Investment Co., Ltd. | 15.10% | −1.98pt | — |
| 2025-04-03 | SBI Investment Co., Ltd. | 17.08% | −2.06pt | pure investment |
| 2025-04-02 | SBI Investment Co., Ltd. | 19.14% | −1.54pt | pure investment |
| 2025-03-31 | ITOCHU Technology Ventures, Inc. | 2.02% | −3.11pt | pure investment |
| 2024-06-19 | ITOCHU Technology Ventures, Inc. | 5.13% | −1.06pt | pure investment |
| 2023-11-28 | SBI Investment Co., Ltd. | 20.68% | −2.16pt | pure investment |
| 2023-11-22 | SBI Investment Co., Ltd. | 22.84% | +1.16pt | pure investment |
Cross-shareholdings
From the annual report's status of shareholdings- Listed strategic holdings
- — issues
- Book value
- —
- Sold in the year
- — — issues
- Bought in the year
- — — issues
- Mutual, both reports
- 0
- Held by listed cos.
- 1
Held by: Alfresa Holdings Corporation 2784
Purposes, all holdings and mutual flags via /v1/companies/4896/cross-holdings. Share changes include stock splits.
Major shareholders
As of fiscal year end 2025-12-31| Shareholder | Shares | Ratio |
|---|---|---|
| individual holder | 2,331,000 | 20.07% |
| SBI Ventures Two株式会社 | 1,726,500 | 14.87% |
| individual holder | 1,177,000 | 10.13% |
| individual holder | 1,166,000 | 10.04% |
| 大和日台バイオベンチャー２号投資事業有限責任組合 | 1,143,000 | 9.84% |
| かごしまバリューアップ投資事業有限責任組合 | 641,000 | 5.52% |
| アルフレッサホールディングス株式会社 | 315,700 | 2.71% |
| テクノロジーベンチャーズ５号投資事業有限責任組合 | 234,800 | 2.02% |
| モルガン・スタンレーＭＵＦＧ証券株式会社 | 99,600 | 0.85% |
| individual holder | 80,000 | 0.68% |
Get this as JSON
GET /v1/companies/4896
GET /v1/companies/4896/financials
GET /v1/companies/4896/details
GET /v1/companies/4896/segments
GET /v1/companies/4896/voting
GET /v1/companies/4896/tender-offers
GET /v1/companies/4896/indicators
GET /v1/companies/4896/earnings-releases
GET /v1/events?ticker=4896
GET /v1/companies/4896/trades
GET /v1/companies/4896/cross-holdings
GET /v1/companies/4896/brief